Baker Hughes Co vs Cronos Group Inc — how do they compare? Baker Hughes Co trades at $64.83 (market cap $63.60B), while Cronos Group Inc trades at $3.08 (market cap $1.11B). The key difference: Baker Hughes Co is far larger — about 57.3× Cronos Group Inc's market cap, and Baker Hughes Co pays a 1.44% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| BKR | CRON | |
|---|---|---|
Market Cap | $63.60B | $1.11B |
Sector | Energy | Health |
52-Week High | $69.67 | $3.27 |
52-Week Low | $42.51 | $2.30 |
Enterprise Value | $64.13B | $310.67M |
Dividend Yield | 1.44% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CRON trades at $3.10 with a 0.98% daily gain, showing bullish technical momentum. The company delivered strong Q2 2026 results with 58% YoY revenue growth and earnings beat, while maintaining #1 market share in Canadian vapes and edibles. Despite negative net income in 2025, revenue growth accelerated to $147M with improving margins. Technical indicators show bullish moving averages but RSI suggests potential overbought conditions near $3 resistance.
Outlook remains positive with international expansion and European cannabis legalization driving growth, though competitive pressures and execution risks persist. Analyst consensus is mixed with 60% hold ratings, reflecting cautious optimism about CRON's turnaround trajectory from previous losses to projected 39% profit margin by 2026.
Trailing returns across standard periods
Latest headlines on both assets
Baker Hughes is a global leader in oilfield services and oilfield equipment, with particularly strong presences in the artificial lift, specialty chemicals, and completions markets. The other half of its business focuses on industrial power generation, process solutions, and industrial asset management, with high exposure to the liquid natural gas market specifically, as well as broader industrials end markets.
Read more on BKR →Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →